Congenital aortopulmonary window

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2037Q21.4
Who is this for?
Show terms as
7Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital aortopulmonary window (also known as aortopulmonary septal defect, aortopulmonary fenestration, or aorticopulmonary window) is a rare congenital heart defect characterized by an abnormal communication (opening) between the ascending aorta and the pulmonary artery in the presence of two separate semilunar valves. This distinguishes it from truncus arteriosus, where there is a single outflow valve. The defect allows oxygenated blood from the aorta to shunt into the pulmonary artery (left-to-right shunt), leading to excessive blood flow to the lungs and volume overload of the left heart chambers. Clinical presentation typically occurs in the neonatal or early infantile period. Affected infants may develop signs of congestive heart failure, including tachypnea (rapid breathing), poor feeding, failure to thrive, recurrent respiratory infections, and a continuous or systolic heart murmur. If left untreated, the persistent high-pressure left-to-right shunt can lead to irreversible pulmonary vascular disease (Eisenmenger syndrome), which carries a very poor prognosis. Associated cardiac anomalies are found in approximately 50% of cases and may include interrupted aortic arch, tetralogy of Fallot, ventricular septal defect, patent ductus arteriosus, and anomalous origin of a coronary artery. Diagnosis is established through echocardiography, often supplemented by cardiac catheterization or CT/MRI angiography. The standard treatment is early surgical repair, ideally performed in infancy before pulmonary vascular disease develops. Surgical closure—either by direct patch closure or division of the communication—has excellent outcomes when performed early, with low operative mortality and good long-term survival. Without surgical intervention, mortality in infancy and early childhood is high. Long-term follow-up after repair is recommended to monitor for residual defects, pulmonary artery stenosis, or aortic regurgitation.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Congenital aortopulmonary window.

View clinical trials →

No actively recruiting trials found for Congenital aortopulmonary window at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital aortopulmonary window community →

Specialists

7 foundView all specialists →
BP
Beatrijs Bartelds, MD, PhD
Specialist
PI on 1 active trial
DM
David Morales, MD
Specialist
PI on 1 active trial
NM
Nathaniel Sznycer-Taub, MD
ANN ARBOR, MI
Specialist
PI on 1 active trial
VM
Vasilis Babaliaros, MD
ATLANTA, GA
Specialist
PI on 1 active trial
BM
Barry T Katzen, MD
BRONX, NY
Specialist
PI on 1 active trial
JM
John R Laird, MD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital aortopulmonary window.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital aortopulmonary windowForum →

No community posts yet. Be the first to share your experience with Congenital aortopulmonary window.

Start the conversation →

Latest news about Congenital aortopulmonary window

No recent news articles for Congenital aortopulmonary window.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital aortopulmonary window

What is Congenital aortopulmonary window?

Congenital aortopulmonary window (also known as aortopulmonary septal defect, aortopulmonary fenestration, or aorticopulmonary window) is a rare congenital heart defect characterized by an abnormal communication (opening) between the ascending aorta and the pulmonary artery in the presence of two separate semilunar valves. This distinguishes it from truncus arteriosus, where there is a single outflow valve. The defect allows oxygenated blood from the aorta to shunt into the pulmonary artery (left-to-right shunt), leading to excessive blood flow to the lungs and volume overload of the left hear

How is Congenital aortopulmonary window inherited?

Congenital aortopulmonary window follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Congenital aortopulmonary window typically begin?

Typical onset of Congenital aortopulmonary window is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Congenital aortopulmonary window?

7 specialists and care centers treating Congenital aortopulmonary window are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.